Versant Venture Management, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Century Therapeutics, Inc. | 0 | 12,166,109 | +12,166,109 | 0 | 27,495,406 | 19.44% | +27,495,406 |
| Contineum Therapeutics, Inc. | 542,628 | 542,628 | 0 | 6,202,238 | 7,086,722 | 5.01% | +884,484 |
| Skye Bioscience, Inc. | 2,007,704 | 2,007,704 | 0 | 1,505,176 | 1,233,935 | 0.87% | -271,241 |
| Tempest Therapeutics, Inc. | 269,772 | 269,772 | 0 | 774,246 | 442,426 | 0.31% | -331,820 |
| CRISPR Therapeutics AG(CRSP) | 148,831 | 148,831 | 0 | 7,804,698 | 7,079,891 | 5.01% | -724,807 |
| Jade Biosciences, Inc. | 1,525,820 | 1,525,820 | 0 | 23,543,403 | 21,437,771 | 15.16% | -2,105,632 |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,382,687 | 3,180,780 | -1,201,907 | 68,720,532 | 52,323,831 | 37.00% | -16,396,701 |
| Lenz Therapeutics, Inc. | 2,656,888 | 2,656,888 | 0 | 42,510,208 | 24,310,525 | 17.19% | -18,199,683 |